Donepezil Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | F | iShares Neuroscience and Healthcare ETF | 0.72 | |
XBI | D | SPDR S&P Biotech ETF | 0.34 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.23 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.18 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.1 |
Compare ETFs
Date | Stock | Title |
---|---|---|
May 15 | AVXL | Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock? |
- Donepezil
Donepezil, sold as the trade name Aricept among others, is a medication used to treat Alzheimer's disease. It appears to result in a small benefit in mental function and ability to function. Use, however, has not been shown to change the progression of the disease. Treatment should be stopped if no benefit is seen. It is taken by mouth.Common side effects include nausea, trouble sleeping, aggression, diarrhea, feeling tired, and muscle cramps. Serious side effects may include abnormal heart rhythms, frequent urge to urinate, and seizures. Donepezil is a centrally acting reversible acetylcholinesterase inhibitor and structurally unrelated to other anticholinesterase agents.Donepezil was approved for medical use in the United States in 1996. It is available as a generic medication. In the United Kingdom a typical month's supply costs the NHS about £0.52 as of 2019. The wholesale cost of this amount in the United States is about US$1.38. In 2017, it was the 127th most commonly prescribed medication in the United States, with more than five million prescriptions.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles